2:56 pm Vertex Pharm: FDA Approves KALYDECO (ivacaftor) for use in eight additional mutations that cause cystic fibrosis
moreView todays social media effects on VRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Vertex is hiring next, click here to view […]